Weekly Thoughts
-
Covid infections reaching climax but vaccines looking too late to save Japan Olympics or its PM
Covid infections and fatalities look to be reaching climaxAs Covid deaths have reached yet another grim milestone of 2mn worldwide and with fatalities in the US approaching 400K, markets are hoping for…
January 17, 2021 -
Dangers of Trump factor diminishing while Japan/South Korean rift warrants close attention
Storming of Capitol by his supporters looking to be Trump’s last hoorah Having for months been pondering the unpredictability of the outgoing US president, as far back as our late June publication underlined…
January 10, 2021 -
We see more vaccines coming this quarter and Topix to outperform NK225 in 2021
The coming oversupply of Covid vaccines As we noted in our last publication, we think that despite the new Covid variants of more contagious forms being detected globally, not only the vaccines approved…
January 2, 2021 -
In 2021, this year’s sector leaders should hugely under-perform the market
Despite bleak short-term outlook, end of pandemic is in sightWe go into 2021 similarly optimistic about Japanese stock market as we were this time last year. We obviously had no idea what…
December 26, 2020 -
US politics dampen sentiment but our bullish stance on Japan stocks remains intact
Politics clouding the market outlook US politics has regained centre stage as policy makers have yet again failed to agree on extending the Covid relief spending programs while the recovery in the US…
December 13, 2020 -
US equity rally broadens as Japan moves to positive YTD; Tech rally forces us to stop loss
US stock market melt-up continues but Japan continues to shine among other DMsContinued excitement over the likelihood of swift approvals of Covid vaccines in the coming month together with a less combative…
November 29, 2020 -
Despite positive vaccine-related undertone, Trump’s tantrums remain a short-term risk
Markets to remain supported by more positive vaccine news to comeAlthough the positive report of high efficacy of Moderna’s Covid vaccine in trial tests did not have nearly the same impact on…
November 22, 2020 -
Covid vaccines could not come soon enough while Japanese stocks shine
Coming vaccines and treatments buoy hopes for 2021 recovery With last week’s Covid vaccine and treatment announcements, rekindling hopes for normalisation, S&P finished the week near its all-time highs first reached in August…
November 15, 2020 -
US stock rally seemed almost pre-programmed; Japan looks best placed DM equity asset class
US stocks rebound despite a contentious election outcome and surging Covid ratesUS stocks bounced strongly last week, despite the fact that market’s worst fears about a potentially contentious US presidential election results…
November 7, 2020 -
Anxieties re-emerge ahead of the US election while earnings look encouraging
US market mood darkens as fears of uncertainties growThe previous week’s subdued stock market proved to be the calm before the storm as the mood has soured once again with US tech…
November 1, 2020